# Colgate Palmolive Co: financial statements, quarterly

CL · NYSE · CIK 21665 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cl.md) · [Financials](/companies/cl/financials.md) · [Filings](/companies/cl/filings.md) · [Insiders](/companies/cl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,915](/filings/0000021665-24-000044.md) | [4,950 d](/filings/0000021665-26-000006.md) | [5,065](/filings/0000021665-25-000020.md) | [5,058](/filings/0000021665-25-000041.md) | [5,033](/filings/0000021665-25-000053.md) | [4,945 d](/filings/0000021665-26-000006.md) | [4,911](/filings/0000021665-26-000023.md) | [5,110](/filings/0000021665-26-000042.md) | [5,131](/filings/0000021665-25-000053.md) | [5,230 d](/filings/0000021665-26-000006.md) | [5,324](/filings/0000021665-26-000023.md) | [5,361](/filings/0000021665-26-000042.md) |
| Cost of revenue | $m | [2,038](/filings/0000021665-24-000044.md) | [2,000 d](/filings/0000021665-26-000006.md) | [2,026](/filings/0000021665-25-000020.md) | [1,992](/filings/0000021665-25-000041.md) | [1,959](/filings/0000021665-25-000053.md) | [1,963 d](/filings/0000021665-26-000006.md) | [1,924](/filings/0000021665-26-000023.md) | [2,041](/filings/0000021665-26-000042.md) | [2,082](/filings/0000021665-25-000053.md) | [2,084 d](/filings/0000021665-26-000006.md) | [2,098](/filings/0000021665-26-000023.md) | [2,065](/filings/0000021665-26-000042.md) |
| Gross profit | $m | [2,877](/filings/0000021665-24-000044.md) | [2,950 d](/filings/0000021665-26-000006.md) | [3,039](/filings/0000021665-25-000020.md) | [3,066](/filings/0000021665-25-000041.md) | [3,074](/filings/0000021665-25-000053.md) | [2,982 d](/filings/0000021665-26-000006.md) | [2,987](/filings/0000021665-26-000023.md) | [3,069](/filings/0000021665-26-000042.md) | [3,049](/filings/0000021665-25-000053.md) | [3,146 d](/filings/0000021665-26-000006.md) | [3,226](/filings/0000021665-26-000023.md) | [3,296](/filings/0000021665-26-000042.md) |
| Selling, general and administrative | $m | [1,822](/filings/0000021665-24-000044.md) | [1,803 d](/filings/0000021665-26-000006.md) | [1,916](/filings/0000021665-25-000020.md) | [1,939](/filings/0000021665-25-000041.md) | [1,979](/filings/0000021665-25-000053.md) | [1,896 d](/filings/0000021665-26-000006.md) | [1,898](/filings/0000021665-26-000023.md) | [1,963](/filings/0000021665-26-000042.md) | [1,971](/filings/0000021665-25-000053.md) | [2,070 d](/filings/0000021665-26-000006.md) | [2,076](/filings/0000021665-26-000023.md) | [2,130](/filings/0000021665-26-000042.md) |
| Operating income | $m | [1,029](/filings/0000021665-24-000044.md) | [1,072 d](/filings/0000021665-26-000006.md) | [1,047](/filings/0000021665-25-000020.md) | [1,092](/filings/0000021665-25-000041.md) | [1,065](/filings/0000021665-25-000053.md) | [1,063 d](/filings/0000021665-26-000006.md) | [1,076](/filings/0000021665-26-000023.md) | [1,080](/filings/0000021665-26-000042.md) | [1,059](/filings/0000021665-25-000053.md) | [92.0 d](/filings/0000021665-26-000006.md) | [964](/filings/0000021665-26-000023.md) | [1,016](/filings/0000021665-26-000042.md) |
| Interest expense | $m | not reported | not reported | [73.0](/filings/0000021665-25-000020.md) | [78.0](/filings/0000021665-25-000041.md) | [74.0](/filings/0000021665-25-000053.md) | [66.0 d](/filings/0000021665-26-000006.md) | [66.0](/filings/0000021665-26-000023.md) | [71.0](/filings/0000021665-26-000042.md) | [67.0](/filings/0000021665-25-000053.md) | [64.0 d](/filings/0000021665-26-000006.md) | [62.0](/filings/0000021665-26-000023.md) | [62.0](/filings/0000021665-26-000042.md) |
| Income tax | $m | [209](/filings/0000021665-24-000044.md) | [228 d](/filings/0000021665-26-000006.md) | [238](/filings/0000021665-25-000020.md) | [243](/filings/0000021665-25-000041.md) | [210](/filings/0000021665-25-000053.md) | [214 d](/filings/0000021665-26-000006.md) | [227](/filings/0000021665-26-000023.md) | [234](/filings/0000021665-26-000042.md) | [226](/filings/0000021665-25-000053.md) | [113 d](/filings/0000021665-26-000006.md) | [211](/filings/0000021665-26-000023.md) | [231](/filings/0000021665-26-000042.md) |
| Net income | $m | [708](/filings/0000021665-24-000044.md) | [718 d](/filings/0000021665-26-000006.md) | [683](/filings/0000021665-25-000020.md) | [731](/filings/0000021665-25-000041.md) | [737](/filings/0000021665-25-000053.md) | [739 d](/filings/0000021665-26-000006.md) | [690](/filings/0000021665-26-000023.md) | [743](/filings/0000021665-26-000042.md) | [735](/filings/0000021665-25-000053.md) | [(37.0) d](/filings/0000021665-26-000006.md) | [646](/filings/0000021665-26-000023.md) | [693](/filings/0000021665-26-000042.md) |
| Diluted EPS | $ per share | [0.86](/filings/0000021665-24-000044.md) | not reported | [0.83](/filings/0000021665-25-000020.md) | [0.89](/filings/0000021665-25-000041.md) | [0.90](/filings/0000021665-25-000053.md) | not reported | [0.85](/filings/0000021665-26-000023.md) | [0.91](/filings/0000021665-26-000042.md) | [0.91](/filings/0000021665-25-000053.md) | not reported | [0.80](/filings/0000021665-26-000023.md) | [0.86](/filings/0000021665-26-000042.md) |
| Basic EPS | $ per share | [0.86](/filings/0000021665-24-000044.md) | not reported | [0.83](/filings/0000021665-25-000020.md) | [0.89](/filings/0000021665-25-000041.md) | [0.90](/filings/0000021665-25-000053.md) | not reported | [0.85](/filings/0000021665-26-000023.md) | [0.92](/filings/0000021665-26-000042.md) | [0.91](/filings/0000021665-25-000053.md) | not reported | [0.81](/filings/0000021665-26-000023.md) | [0.87](/filings/0000021665-26-000042.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000021665-23-000037.md) | [1.0](/filings/0000021665-25-000008.md) | [1.1](/filings/0000021665-24-000015.md) | [1.1](/filings/0000021665-24-000031.md) | [1.2](/filings/0000021665-24-000044.md) | [1.1](/filings/0000021665-26-000006.md) | [1.1](/filings/0000021665-25-000020.md) | [1.2](/filings/0000021665-25-000041.md) | [1.3](/filings/0000021665-25-000053.md) | [1.3](/filings/0000021665-26-000042.md) | [1.3](/filings/0000021665-26-000023.md) | [1.4](/filings/0000021665-26-000042.md) |
| Current assets | $bn | [5.4](/filings/0000021665-23-000037.md) | [5.3](/filings/0000021665-25-000008.md) | [5.6](/filings/0000021665-24-000015.md) | [5.6](/filings/0000021665-24-000031.md) | [5.8](/filings/0000021665-24-000044.md) | [5.3](/filings/0000021665-26-000006.md) | [5.8](/filings/0000021665-25-000020.md) | [6.0](/filings/0000021665-25-000041.md) | [6.0](/filings/0000021665-25-000053.md) | [5.7](/filings/0000021665-26-000042.md) | [6.1](/filings/0000021665-26-000023.md) | [6.3](/filings/0000021665-26-000042.md) |
| Total assets | $bn | [16.0](/filings/0000021665-23-000037.md) | [16.4](/filings/0000021665-25-000008.md) | [16.6](/filings/0000021665-24-000015.md) | [16.5](/filings/0000021665-24-000031.md) | [16.8](/filings/0000021665-24-000044.md) | [16.0](/filings/0000021665-26-000006.md) | [16.6](/filings/0000021665-25-000020.md) | [17.5](/filings/0000021665-25-000041.md) | [17.5](/filings/0000021665-25-000053.md) | [16.3](/filings/0000021665-26-000042.md) | [16.6](/filings/0000021665-26-000023.md) | [16.8](/filings/0000021665-26-000042.md) |
| Current liabilities | $bn | [4.6](/filings/0000021665-23-000037.md) | [4.7](/filings/0000021665-25-000008.md) | [5.3](/filings/0000021665-24-000015.md) | [5.4](/filings/0000021665-24-000031.md) | [5.6](/filings/0000021665-24-000044.md) | [5.8](/filings/0000021665-26-000006.md) | [6.9](/filings/0000021665-25-000020.md) | [6.8](/filings/0000021665-25-000041.md) | [6.5](/filings/0000021665-25-000053.md) | [6.9](/filings/0000021665-26-000042.md) | [5.9](/filings/0000021665-26-000023.md) | [6.1](/filings/0000021665-26-000042.md) |
| Total liabilities | $bn | [15.6](/filings/0000021665-23-000037.md) | [15.4](/filings/0000021665-25-000008.md) | [16.0](/filings/0000021665-24-000015.md) | [16.0](/filings/0000021665-24-000031.md) | [15.9](/filings/0000021665-24-000044.md) | [15.5](/filings/0000021665-26-000006.md) | [15.9](/filings/0000021665-25-000020.md) | [16.4](/filings/0000021665-25-000041.md) | [16.3](/filings/0000021665-25-000053.md) | [16.0](/filings/0000021665-26-000042.md) | [16.1](/filings/0000021665-26-000023.md) | [16.2](/filings/0000021665-26-000042.md) |
| Long-term debt | $bn | [8.7](/filings/0000021665-23-000037.md) | [8.2](/filings/0000021665-25-000008.md) | [8.2](/filings/0000021665-24-000015.md) | [8.1](/filings/0000021665-24-000031.md) | [7.9](/filings/0000021665-24-000044.md) | [7.3](/filings/0000021665-26-000006.md) | [6.6](/filings/0000021665-25-000020.md) | [7.1](/filings/0000021665-25-000041.md) | [7.3](/filings/0000021665-25-000053.md) | [6.9](/filings/0000021665-26-000042.md) | [7.9](/filings/0000021665-26-000023.md) | [7.8](/filings/0000021665-26-000042.md) |
| Current portion of debt | $bn | [0.0](/filings/0000021665-23-000037.md) | [0.0](/filings/0000021665-25-000008.md) | [0.0](/filings/0000021665-24-000015.md) | [0.0](/filings/0000021665-24-000031.md) | [0.0](/filings/0000021665-24-000044.md) | [0.7](/filings/0000021665-26-000006.md) | [1.7](/filings/0000021665-25-000020.md) | not reported | not reported | [1.1](/filings/0000021665-26-000006.md) | not reported | not reported |
| Shareholders' equity | $bn | [(0.0)](/filings/0000021665-23-000037.md) | [0.6](/filings/0000021665-25-000008.md) | [0.2](/filings/0000021665-24-000015.md) | [0.1](/filings/0000021665-24-000031.md) | [0.4](/filings/0000021665-24-000044.md) | [0.2](/filings/0000021665-26-000006.md) | [0.4](/filings/0000021665-25-000020.md) | [0.7](/filings/0000021665-25-000041.md) | [0.9](/filings/0000021665-25-000053.md) | [0.1](/filings/0000021665-26-000042.md) | [0.1](/filings/0000021665-26-000023.md) | [0.2](/filings/0000021665-26-000042.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,152 d](/filings/0000021665-24-000044.md) | [1,136 d](/filings/0000021665-26-000006.md) | [681](/filings/0000021665-25-000020.md) | [990 d](/filings/0000021665-25-000041.md) | [1,167 d](/filings/0000021665-25-000053.md) | [1,269 d](/filings/0000021665-26-000006.md) | [600](/filings/0000021665-26-000023.md) | [884 d](/filings/0000021665-26-000042.md) | [1,261 d](/filings/0000021665-25-000053.md) | [1,453 d](/filings/0000021665-26-000006.md) | [747](/filings/0000021665-26-000023.md) | [995 d](/filings/0000021665-26-000042.md) |
| Capital expenditure | $m | [161 d](/filings/0000021665-24-000044.md) | [197 d](/filings/0000021665-26-000006.md) | [126](/filings/0000021665-25-000020.md) | [117 d](/filings/0000021665-25-000041.md) | [134 d](/filings/0000021665-25-000053.md) | [184 d](/filings/0000021665-26-000006.md) | [124](/filings/0000021665-26-000023.md) | [108 d](/filings/0000021665-26-000042.md) | [155 d](/filings/0000021665-25-000053.md) | [177 d](/filings/0000021665-26-000006.md) | [138](/filings/0000021665-26-000023.md) | [128 d](/filings/0000021665-26-000042.md) |
| Share repurchases | $m | [332 d](/filings/0000021665-24-000044.md) | [245 d](/filings/0000021665-26-000006.md) | [509](/filings/0000021665-25-000020.md) | [480 d](/filings/0000021665-25-000041.md) | [295 d](/filings/0000021665-25-000053.md) | [455 d](/filings/0000021665-26-000006.md) | [284](/filings/0000021665-26-000023.md) | [232 d](/filings/0000021665-26-000042.md) | [288 d](/filings/0000021665-25-000053.md) | [406 d](/filings/0000021665-26-000006.md) | [306](/filings/0000021665-26-000023.md) | [291 d](/filings/0000021665-26-000042.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [839](/filings/0000021665-23-000037.md) | [833](/filings/0000021665-24-000015.md) | [831](/filings/0000021665-24-000031.md) | [827](/filings/0000021665-24-000044.md) | [826](/filings/0000021665-25-000020.md) | [824](/filings/0000021665-25-000041.md) | [823](/filings/0000021665-25-000053.md) | [815](/filings/0000021665-26-000023.md) | [813](/filings/0000021665-26-000042.md) | [810](/filings/0000021665-25-000053.md) | [805](/filings/0000021665-26-000023.md) | [802](/filings/0000021665-26-000042.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 797,172,829 at 2026-06-30, from the cover of the [10-Q filed 2026-07-31](/filings/0000021665-26-000042.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.